share_log

8-K: Current report

SEC ·  Dec 20, 2024 08:00

Summary by Moomoo AI

Nukkleus announced a $10 million private placement with a New York-based family office investor on December 18, 2024. The company will issue 1,666,666 units at $6.00 per unit, with each unit comprising one common stock share and a warrant to purchase 1.5 additional shares. The warrants are exercisable at $6.00 per share with a five-year term.The proceeds will primarily fund the acquisition of Star 26 Capital Inc., which holds 95% ownership in RIMON, a key supplier of components for Israel's Iron Dome missile defense system. The offering, priced above market under Nasdaq rules, is expected to close around December 19, with Dawson James Securities serving as the exclusive placement agent.Additionally, the company granted 1,337,500 restricted stock shares to executives and directors on December 16, including 500,000 shares to Menachem Shalom and 150,000 shares to Anastasiia Kotaieva, compensating them for extended service with limited prior compensation.
Nukkleus announced a $10 million private placement with a New York-based family office investor on December 18, 2024. The company will issue 1,666,666 units at $6.00 per unit, with each unit comprising one common stock share and a warrant to purchase 1.5 additional shares. The warrants are exercisable at $6.00 per share with a five-year term.The proceeds will primarily fund the acquisition of Star 26 Capital Inc., which holds 95% ownership in RIMON, a key supplier of components for Israel's Iron Dome missile defense system. The offering, priced above market under Nasdaq rules, is expected to close around December 19, with Dawson James Securities serving as the exclusive placement agent.Additionally, the company granted 1,337,500 restricted stock shares to executives and directors on December 16, including 500,000 shares to Menachem Shalom and 150,000 shares to Anastasiia Kotaieva, compensating them for extended service with limited prior compensation.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more